Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 studyBergsten, Elisabet ; Horne, AnnaCarin ; Aricó, Maurizio ; Astigarraga, Itziar ; Egeler, R. Maarten ; Filipovich, Alexandra H. ; Ishii, Eiichi ; Janka, Gritta ; Ladisch, Stephan ; Lehmberg, Kai ; McClain, Kenneth L. ; Minkov, Milen ; Montgomery, Scott ; Nanduri, Vasanta ; Rosso, Diego ; Henter, Jan-IngeBlood, 2017-12, Vol.130 (25), p.2728-2738 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
2 |
Material Type: Artigo
|
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung CancerSenan, Suresh ; Brade, Anthony ; Wang, Lu-Hua ; Vansteenkiste, Johan ; Dakhil, Shaker ; Biesma, Bonne ; Martinez Aguillo, Maite ; Aerts, Joachim ; Govindan, Ramaswamy ; Rubio-Viqueira, Belén ; Lewanski, Conrad ; Gandara, David ; Choy, Hak ; Mok, Tony ; Hossain, Anwar ; Iscoe, Neill ; Treat, Joseph ; Koustenis, Andrew ; San Antonio, Bélen ; Chouaki, Nadia ; Vokes, EverettJournal of clinical oncology, 2016-03, Vol.34 (9), p.953-962 [Periódico revisado por pares]United StatesTexto completo disponível |
|
3 |
Material Type: Artigo
|
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 studyLe Treut, J. ; Sault, M.C. ; Lena, H. ; Souquet, P.J. ; Vergnenegre, A. ; Le Caer, H. ; Berard, H. ; Boffa, S. ; Monnet, I. ; Damotte, D. ; Chouaid, C.Annals of oncology, 2013-06, Vol.24 (6), p.1548-1552 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer : JCOG 9702OKAMOTO, H ; WATANABE, K ; KUNIKANE, H ; YOKOYAMA, A ; KUDOH, S ; ASAKAWA, T ; SHIBATA, T ; KUNITOH, H ; TAMURA, T ; SAIJO, NBritish journal of cancer, 2007-07, Vol.97 (2), p.162-169 [Periódico revisado por pares]Basingstoke: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. OncologyHanna, Nasser ; Neubauer, Marcus ; Yiannoutsos, Constantin ; McGarry, Ronald ; Arseneau, James ; Ansari, Rafat ; Reynolds, Craig ; Govindan, Ramaswamy ; Melnyk, Anton ; Fisher, William ; Richards, Donald ; Bruetman, Daniel ; Anderson, Thomas ; Chowhan, Naveed ; Nattam, Sreenivasa ; Mantravadi, Prasad ; Johnson, Cynthia ; Breen, Tim ; White, Angela ; Einhorn, LawrenceJournal of clinical oncology, 2008-12, Vol.26 (35), p.5755-5760 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Increased amounts and stability of telomeric repeat-containing RNA (TERRA) following DNA damage induced by etoposideOh, Bong-Kyeong ; Choi, Yoojung ; Bae, Jaeman ; Lee, Won Moo ; Hoh, Jeong-Kyu ; Choi, Joong Sub Lustig, Arthur J.PloS one, 2019-11, Vol.14 (11), p.e0225302 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
|
7 |
Material Type: Artigo
|
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 StudyRudin, Charles M ; Awad, Mark M ; Navarro, Alejandro ; Gottfried, Maya ; Peters, Solange ; Csőszi, Tibor ; Cheema, Parneet K ; Rodriguez-Abreu, Delvys ; Wollner, Mirjana ; Yang, James Chih-Hsin ; Mazieres, Julien ; Orlandi, Francisco J ; Luft, Alexander ; Gümüş, Mahmut ; Kato, Terufumi ; Kalemkerian, Gregory P ; Luo, Yiwen ; Ebiana, Victoria ; Pietanza, M Catherine ; Kim, Hye RyunJournal of clinical oncology, 2020-07, Vol.38 (21), p.2369-2379 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
8 |
Material Type: Artigo
|
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)Liu, Stephen V ; Reck, Martin ; Mansfield, Aaron S ; Mok, Tony ; Scherpereel, Arnaud ; Reinmuth, Niels ; Garassino, Marina Chiara ; De Castro Carpeno, Javier ; Califano, Raffaele ; Nishio, Makoto ; Orlandi, Francisco ; Alatorre-Alexander, Jorge ; Leal, Ticiana ; Cheng, Ying ; Lee, Jong-Seok ; Lam, Sivuonthanh ; McCleland, Mark ; Deng, Yu ; Phan, See ; Horn, LeoraJournal of clinical oncology, 2021-02, Vol.39 (6), p.619-630 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
9 |
Material Type: Artigo
|
Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case reportSun, Li ; Yang, Meng ; Zhang, Xuan ; Li, Hua ; Wu, Lingying ; Zhang, Yuzi ; Cai, ShangliMedicine (Baltimore), 2020-05, Vol.99 (20), p.e20053-e20053 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
|
10 |
Material Type: Artigo
|
First‐Line Durvalumab in Addition to Etoposide and Platinum for Extensive‐Stage Small Cell Lung Cancer: A U.S.‐Based Cost‐Effectiveness AnalysisLin, Shen ; Luo, Shaohong ; Gu, Dian ; Li, Meiyue ; Rao, Xin ; Wang, Changlian ; Huang, Pinfang ; Xu, Xiongwei ; Weng, XiuhuaThe oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.e2013-e2020 [Periódico revisado por pares]Hoboken, USA: John Wiley & Sons, IncTexto completo disponível |